OSE Immunotherapeutics S.A.
OSE Immunotherapeutics SA, a clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally. Its products include Tedopi that is in Phase III clinical trial for the treatment of non-small cell lung cancer, as well as in Phase II clinical trial to pancreatic and ovarian cancer; OSE-279, which is in a Phase I/II c… Read more
Market Cap & Net Worth: OSE Immunotherapeutics S.A. (0RAD)
OSE Immunotherapeutics S.A. (LSE:0RAD) has a market capitalization of $52.80 Million (€51.43 Million) as of March 19, 2026. Listed on the LSE stock exchange, this UK-based company holds position #20567 globally and #378 in its home market, demonstrating a -9.97% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying OSE Immunotherapeutics S.A.'s stock price €3.52 by its total outstanding shares 14612100 (14.61 Million).
OSE Immunotherapeutics S.A. Market Cap History: 2026 to 2026
OSE Immunotherapeutics S.A.'s market capitalization history from 2026 to 2026. Data shows growth from $52.80 Million to $52.80 Million (0.00% CAGR).
OSE Immunotherapeutics S.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how OSE Immunotherapeutics S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 0RAD by Market Capitalization
Companies near OSE Immunotherapeutics S.A. in the global market cap rankings as of March 19, 2026.
Key companies related to OSE Immunotherapeutics S.A. by market ranking:
- Roda Vivatex Tbk (JK:RDTX): Ranked #20558 globally with a market cap of $57.58 Million USD ( Rp936.71 Billion IDR).
- Research Solutions Inc (NASDAQ:RSSS): Ranked #20559 globally with a market cap of $57.56 Million USD.
- 1895 of Wisconsin Inc Bancorp (NASDAQ:BCOW): Ranked #20568 globally with a market cap of $57.43 Million USD.
- Helius Medical Technologies Inc Class A (NASDAQ:HSDT): Ranked #20569 globally with a market cap of $57.40 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #20558 | Roda Vivatex Tbk | JK:RDTX | $57.58 Million | Rp16475.00 |
| #20559 | Research Solutions Inc | NASDAQ:RSSS | $57.56 Million | $2.29 |
| #20568 | 1895 of Wisconsin Inc Bancorp | NASDAQ:BCOW | $57.43 Million | $10.93 |
| #20569 | Helius Medical Technologies Inc Class A | NASDAQ:HSDT | $57.40 Million | $2.07 |
OSE Immunotherapeutics S.A. Historical Marketcap From 2026 to 2026
Between 2026 and today, OSE Immunotherapeutics S.A.'s market cap moved from $52.80 Million to $ 52.80 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €52.80 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of OSE Immunotherapeutics S.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $52.80 Million USD |
| MoneyControl | $52.80 Million USD |
| MarketWatch | $52.80 Million USD |
| marketcap.company | $52.80 Million USD |
| Reuters | $52.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.